Potently neutralizing and protective human antibodies against SARS-CoV-2Seth J. Zost, James E. Crowe, Pavlo Gilchuk et al.|Nature|2020Cited by 1.2k
Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animalsSeth J. Zost, James E. Crowe, Pavlo Gilchuk et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 51
Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodiesCharles D. Murin, Andrew B. Ward, Pavlo Gilchuk et al.|Cell Reports|2021Cited by 33
Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER regionClara T. Schoeder, Jens Meiler, Pavlo Gilchuk et al.|PLoS Pathogens|2022Cited by 21
Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement systemPhilipp A. Ilinykh, Alexander Bukreyev, Kai Huang et al.|Communications Biology|2024Cited by 6